FR2607136B1 - Ligands et procedes pour augmenter la proliferation des cellules b et pour supprimer la proliferation des cellules qui expriment bp50 - Google Patents

Ligands et procedes pour augmenter la proliferation des cellules b et pour supprimer la proliferation des cellules qui expriment bp50

Info

Publication number
FR2607136B1
FR2607136B1 FR878708245A FR8708245A FR2607136B1 FR 2607136 B1 FR2607136 B1 FR 2607136B1 FR 878708245 A FR878708245 A FR 878708245A FR 8708245 A FR8708245 A FR 8708245A FR 2607136 B1 FR2607136 B1 FR 2607136B1
Authority
FR
France
Prior art keywords
cells
proliferation
ligands
express
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR878708245A
Other languages
English (en)
Other versions
FR2607136A1 (fr
Inventor
Jeffrey A Ledbetter
Edward A Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of FR2607136A1 publication Critical patent/FR2607136A1/fr
Application granted granted Critical
Publication of FR2607136B1 publication Critical patent/FR2607136B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0635—B lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR878708245A 1986-06-13 1987-06-12 Ligands et procedes pour augmenter la proliferation des cellules b et pour supprimer la proliferation des cellules qui expriment bp50 Expired FR2607136B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87388486A 1986-06-13 1986-06-13

Publications (2)

Publication Number Publication Date
FR2607136A1 FR2607136A1 (fr) 1988-05-27
FR2607136B1 true FR2607136B1 (fr) 1989-09-15

Family

ID=25362524

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878708245A Expired FR2607136B1 (fr) 1986-06-13 1987-06-12 Ligands et procedes pour augmenter la proliferation des cellules b et pour supprimer la proliferation des cellules qui expriment bp50

Country Status (22)

Country Link
JP (1) JPH0762040B2 (fr)
KR (1) KR910004100B1 (fr)
AT (1) AT398437B (fr)
AU (1) AU617087B2 (fr)
BE (1) BE1000587A4 (fr)
CA (1) CA1338781C (fr)
CH (1) CH676600A5 (fr)
CY (1) CY1681A (fr)
DE (1) DE3719398C2 (fr)
DK (1) DK173940B1 (fr)
FR (1) FR2607136B1 (fr)
GB (1) GB2191494B (fr)
GR (1) GR870930B (fr)
HK (1) HK10293A (fr)
IE (1) IE60486B1 (fr)
IL (1) IL82841A (fr)
IT (1) IT1208649B (fr)
LU (1) LU86919A1 (fr)
NL (1) NL195022C (fr)
PT (1) PT85073B (fr)
SE (1) SE504675C2 (fr)
SG (1) SG118992G (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
CO4600681A1 (es) 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma Composicion farmaceutica para la modulacion inmunitaria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
EP0117705A3 (fr) * 1983-02-24 1985-09-25 The Regents Of The University Of California Anticorps monoclonal spécifique des monocytes et des cellules blastiques
FR2547731A1 (fr) * 1983-06-27 1984-12-28 Centre Nat Rech Scient Immunotoxine antitumorale, preparations pharmaceutiques la contenant et son utilisation in vitro
US4585742A (en) * 1983-12-14 1986-04-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibody with specificity to human small cell carcinoma and use thereof

Also Published As

Publication number Publication date
PT85073B (pt) 1990-07-31
GR870930B (en) 1987-12-16
SE504675C2 (sv) 1997-04-07
SG118992G (en) 1993-01-29
DK302287A (da) 1987-12-14
HK10293A (en) 1993-02-19
NL8701371A (nl) 1988-01-04
NL195022C (nl) 2003-06-18
IE60486B1 (en) 1994-07-27
CH676600A5 (fr) 1991-02-15
KR880000582A (ko) 1988-03-28
GB2191494B (en) 1990-08-22
AU7421487A (en) 1987-12-17
DK173940B1 (da) 2002-03-04
BE1000587A4 (fr) 1989-02-14
CY1681A (en) 1993-10-10
DK302287D0 (da) 1987-06-12
IT1208649B (it) 1989-07-10
KR910004100B1 (ko) 1991-06-22
FR2607136A1 (fr) 1988-05-27
DE3719398A1 (de) 1988-01-28
IL82841A (en) 1992-11-15
ATA151387A (de) 1994-04-15
IT8720899A0 (it) 1987-06-12
JPS6480299A (en) 1989-03-27
GB8713650D0 (en) 1987-07-15
DE3719398C2 (de) 1996-03-28
AU617087B2 (en) 1991-11-21
PT85073A (en) 1987-07-01
GB2191494A (en) 1987-12-16
IL82841A0 (en) 1987-12-20
SE8702463L (sv) 1987-12-14
CA1338781C (fr) 1996-12-10
AT398437B (de) 1994-12-27
IE871563L (en) 1987-12-13
SE8702463D0 (sv) 1987-06-12
LU86919A1 (fr) 1989-03-08
JPH0762040B2 (ja) 1995-07-05

Similar Documents

Publication Publication Date Title
DK160173C (da) Praeparat og middel til behandling af fiskefileter
IT1171646B (it) Composti benzoeterociclici e procedimento per prepararli
MX164962B (es) Mejoras en metodo de deshidrociclizar alcanos
BR8206881A (pt) Vela de efeitos propulsor e de sustentacao variaveis
IT1177375B (it) Composizione e procedimento per inibire le incrostazioni
IT1169243B (it) Composizione e procedimento per rimouvere metallo
DK512084D0 (da) Siliconeemulsion og polermiddel indeholdende samme
FR2607136B1 (fr) Ligands et procedes pour augmenter la proliferation des cellules b et pour supprimer la proliferation des cellules qui expriment bp50
IT1181867B (it) Apparecchio e procedimento per esaminare e selezionare contenitori trasparenti
DK97585A (da) Holder til umiddelbar fastholdelse og opbevaring af loese genstande
ES487982A0 (es) Metodo de preparar 3-0-(beta-d-glucuronopiranosil)-sojasapo-genol b y similares
DK331581A (da) Saltlage og fremgangsmaade til anvendelse deraf
DE3169978D1 (en) T-assembly and method to obtain it
NO151460C (no) Fremgangsmaate og fremstilling av 2-fluorerte metylaminoacetonitriler
IT8447772A0 (it) Disposizione di conchiglie per colata continua regolabili
PH24747A (en) Novel aryloxycycloalkanolaminoalkylene aryl ketons and method of use thereof
DK363583A (da) Tobakspung og fremgangsmaade til fremstilling heraf
IT8122696A0 (it) Paletta per sostenere corpi sagomati ceramici
JPS55159029A (en) Method of manipulating and adjusting dredger
GR65670B (en) Method of polymerism in suspension
RO92590A (fr) Procede et four-tunnel pour la cuisson des pieces ceramiques
JPS5455015A (en) Method of bonding copper and ceramic
DK113583D0 (da) Fremstilling af mono- og dibromeller chloraldehyder og syrechlorider
IT1194823B (it) Composizione di rivestimento di elettrodeposito catodico e procedimento per ottenerla
JPS54117327A (en) Removing of copper and spinnel shaped scale